NTRK1 and gastrointestinal stromal tumor: In particular, GIST commonly shows activating mutations in the receptor tyrosine kinases KIT and PDGFRA. While physiological KIT or PDGFRα signaling are involved in cell differentiation and survival, activating mutations in both genes results in constitutive ligand‐independent receptor activation, leading to GIST tumorigenesis.